Patient reported outcomes (PROs) of multiple myeloma (MM) patients from the PANORAMA-1 study who have received at least two prior regimens including bortezomib and an immunomodulatory agent
Patient reported outcomes (PROs) of multiple myeloma (MM) patients from the PANORAMA-1 study who have received at least two prior regimens including bortezomib and an immunomodulatory agent
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2016
Authors:
Richardson, PG Hungria, V Yoon, SS Beksac, M Dimopoulos, MA Elghandour, A Jedrzejczak, WW Nakorn, TN Siritanaratkul, N Schlossman, R others
